Mette Krog Josiassen

Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial

Messoud Ashina, Michel Lantéri‐Minet, Patricia Pozo‐Rosich et al. · The Lancet Neurology · 2022 · 150 citations

Cluster Headache, Clinical Trials, Migraine Prevention +5

Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials

George T. Grossberg, Eva Kohegyi, Victor Mergel et al. · American Journal of Geriatric Psychiatry · 2019 · 145 citations

Effects of Intravenous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack

Paul Winner, Peter McAllister, George Chakhava et al. · JAMA · 2021 · 96 citations · Full text

Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study

Mary Hobart, Aleksandar Skuban, Peter Zhang et al. · Current Medical Research and Opinion · 2018 · 59 citations · Full text

Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials

Timothy R. Smith, Egilius L.H. Spierings, Roger Cady et al. · The Journal of Headache and Pain · 2021 · 45 citations · Full text